Komori
Mitsubishi Kakoki (6331) · RiskRestated

Failure to Achieve Sales Targets for New Products and Technologies

First written in FY2016. 2 of 3 entries say "Restated". Latest entry: FY2018.

3entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20182016: 120162017: 120172018: 12018
Same theme, other companies
Risk that original and new products fail to achieve market acceptanceA theme 29 companies write about · 29 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2024: 3 of 7 companies on the "Worse" side.

15 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 29 companies compared. The sentences above are computed from all 29.
Full recordFilings, disclosures and news, newest first
  1. FY2018RestatedAnnual report

    「If new products and technologies developed through research and development, or technologies introduced through technical alliances, fail to meet their sales targets, this may adversely affect the performance and financial position of our group.」

    The company continues to disclose the risk that the results of R&D and technical alliances may fail to meet sales targets.
  2. FY2017RestatedAnnual report

    「If new products and technologies developed through research and development, or technologies introduced through technical alliances, fail to meet their sales targets, this may adversely affect the performance and financial position of our group.」

    The company continues to disclose the risk that the results of R&D and technical alliances may fail to meet sales targets.
  3. FY2016First statedAnnual report

    「If new products and technologies developed through research and development, or technologies introduced through technical alliances, fail to meet their sales targets, this may adversely affect the performance and financial position of our group.」

    Commercialisation risk associated with R&D investment and technology adoption in growth areas.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Mitsubishi Kakoki's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Failure to Achieve Sales Targets for New Products and Technologies | Mitsubishi Kakoki Kaisha,Ltd. (6331) | Komori